Screener
Lucid Diagnostics LUCD EPS (Diluted)
Discontinued — last reported Q3 '25
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Lucid Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Lucid Diagnostics’s 10-Q, filed November 12, 2025. Open the filing →
- Filed
- Nov 12, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001493152-25-021737
FAQ
- What is Lucid Diagnostics's EPS (diluted)?
- Lucid Diagnostics (LUCD) reported EPS (diluted) of -$0.10 in Q3 2025.
- How has Lucid Diagnostics's EPS (diluted) changed year-over-year?
- Lucid Diagnostics's EPS (diluted) increased by 60.0% year-over-year, from -$0.25 to -$0.10.
- What is the long-term trend for Lucid Diagnostics's EPS (diluted)?
- Over 2 years (2022 to 2024), Lucid Diagnostics's EPS (diluted) has grown at a -17.3% compound annual growth rate (CAGR), from -$1.55 to -$1.06.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Lucid Diagnostics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude